Source
Marketwire
Date 01/06/2016
Time 06:02:21 AM
Company
ALLIANCEPHARMA INC.
Title AlliancePharma Inc. Launches Logistik Pharma, a New Subsidiary
Specializing in Pharmacy Laboratory Reengineering
CDNX Symbol: APA
Press Release
NEWS RELEASE TRANSMITTED BY MARKETWIRED
FOR: AlliancePharma Inc.
TSX VENTURE SYMBOL: APA
January 6, 2016
AlliancePharma Inc. Launches Logistik Pharma, a New Subsidiary
Specializing in
Pharmacy Laboratory Reengineering
THETFORD MINES, QUEBEC--(Marketwired - Jan. 6, 2016) - AlliancePharma
Inc. (TSX
VENTURE:APA) ("AlliancePharma" or "the Company") launches Logistik
Pharma, a
new subsidiary dedicated to increasing the profitability of pharmacies by
optimizing laboratory work organization and patient management. This new
integrated optimization process aims to improve the quality of
pharmaceutical
services to patients, while increasing the profitability of the pharmacy.
"AlliancePharma stands out as a leader in professional services and
wishes to
offer all pharmacies in Quebec a wide range of resources and powerful
tools
allowing them to tap into new market trends. By improving their
laboratory
structure, pharmacists will be able to maximize profitability at all
stages of
the process while improving the quality of life of their patients", said
Marc
Lemieux, Chairman of the Board, President and CEO of AlliancePharma.
Greater pharmacy efficiency
Logistik Pharma reviews all activities performed in the laboratory, from
inventory management to the content delegation through the support of
patients
services and workflow enhancement.
Logistik Pharma also offers training services involving the integration
of new
acts arising out of Bill 41, the establishment of compliance procedures,
as
well as patient follow up and billing.
About AlliancePharma
AlliancePharma is the leader in professional services and replacement
pharmacists and pharmacy technicians in Quebec. The quality of its
customer
service and professional services rendered reflect the expertise of the
Company. Management's vision is to expand and diversify its activities to
become a key player in the health services industry in Quebec, the rest
of
Canada and internationally. Additional information regarding the Company
is
available at www.alliancepharmainc.ca and on SEDAR at www.sedar.com.
This press release contains forward-looking statements to which are
associated
some risks and uncertainties. Any statement contained in this present
press
release that does not constitute an historical fact can be considered as
a
forward-looking statement. Those statements do not warrant as for the
future
performance of AlliancePharma Inc. and they suppose known and unknown
risks as
well as uncertainties in such a way that true future perspectives,
returns or
results of the Company may be different of future returns or results
expressed
or implied by these forward-looking statements. AlliancePharma Inc. does
not
accept responsibility for the accuracy and the completeness of those
forward-looking statements and does not undertake to publicly review such
statements to adapt to new events or circumstance.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as
that
term is defined in policies of the TSX Venture Exchange) accepts
responsibility
for the adequacy or accuracy of this release.
- 30 CONTACT INFO:
Patrick Fernet
Global Impact Service g.p.
(514) 796-8787
investir@alliancepharma.ca
INDUSTRY: Media and Entertainment - Information Services, Pharmaceuticals
and
Biotech - Biotech
SUBJECT: PDT - NEW PRODUCTS/SERVICES
---------------------------------------------Suite 900, 25 York Street, Toronto, ON M5J 2V5
Toll Free:888-299-0338
Phone: 416-362-0885
info@marketwired.com
---------------------------------------------If you no longer want to receive
announcements from us, please do not reply to this e-mail.
Instead simply click
http://marketwire.com/mw/fmu.jsp?id=553645097